Get your Cancer Gene Therapy paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.9
Authored by Sumalatha Gangadhar | Published on 3 August, 2026
Submitting to Cancer Gene Therapy goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Cancer Gene Therapy guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Cancer Gene Therapy. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Cancer Gene Therapy journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Cancer Gene Therapy guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Cancer Gene Therapy guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
| Element | Cancer Gene Ther requirement |
|---|---|
| Abstract | Unstructured abstract, maximum 200 words for Articles, Review Articles, and Brief Communications. No abstract required for Perspectives and Correspondence |
| Main text | Article: Main body maximum 12,000 words (excluding tables/figures and references), max 7 tables or figures, max 60 references. Review Article: Main body maximum 4,000 words (excluding abstract, tables/figures, and references), max 7 tables or figures, max 120 references. Brief Communication: Main body no more than 2 pages (excluding abstract, tables/figures, and references), max 1 table or figure, max 10 references. Perspective: Main body maximum 2,000 words (excluding tables/figures and references), max 4 tables and/or figures, max 25 references. Correspondence: No specified limits |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | Editor-assigned subject terms from journal's subject ontology: 1-4 unique subject terms required to describe key subjects and concepts. Not traditional author-supplied keywords |
| References | Vancouver format. References numbered sequentially in order of citation in text. All authors listed for papers with up to 6 authors; for papers with more than 6 authors, first six listed followed by et al. Journal abbreviations follow Index Medicus |
| Peer review | Single anonymized (single-blind). Identity transparency: Single anonymized. Reviewer interacts with: Editor. Review information published: None |
| Submission | mts-cgt.nature.com/cgi-bin/main.plex |
Read the Cancer Gene Therapy guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Cancer Gene Therapy in under a page.
Skim two or three recent Cancer Gene Ther papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Cancer Gene Therapy journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Cancer Gene Therapy guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.